Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 117701 - 117720 out of 498429 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Croatia | (L01FD01) trastuzumab | Kanjinti | boč. 1x420 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AmgenEuropeB.V. / AmgenEuropeB.V. |
Croatia | (L01FD01) trastuzumab | Zercepac | boč. 1x420 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Stomach Neoplasms | AccordHealthcareS.L.U. / AccordHealthcareLimited,AccordHealthcarePolskaSp.zo.o. |
Croatia | (L01FD01) trastuzumab | Zercepac | boč. 1x60 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Stomach Neoplasms | AccordHealthcareS.L.U. / AccordHealthcareLimited,AccordHealthcarePolskaSp.zo.o. |
Croatia | (L01FD02) pertuzumab | Perjeta | konc. za otop. za inf., boč. stakl. 1x420 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH / RochePharmaAG |
Croatia | (L01FD03) trastuzumab emtansine | Kadcyla | praš. za konc. za otop. za inf., boč. stakl. 1x100 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH / RochePharmaAG |
Croatia | (L01FD03) trastuzumab emtansine | Kadcyla | praš. za konc. za otop. za inf., boč. stakl. 1x160 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH / RochePharmaAG |
Croatia | (L01FE02) panitumumab | Vectibix | konc. za otop. za inf., boč. 1x5 ml (20 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V. / AmgenEuropeB.V. |
Croatia | (L01FF01) nivolumab | Opdivo | konc. za otop. za inf., boč. stakl. 1x4 ml (10 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG / Bristol-MyersSquibbS.r.l. |
Croatia | (L01FF01) nivolumab | Opdivo | konc. za otop. za inf., boč. stakl. 1x10 ml (10 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG / Bristol-MyersSquibbS.r.l. |
Croatia | (L01FF01) nivolumab | Opdivo | konc. za otop. za inf., boč. stakl. 1x24 ml (10 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG / Bristol-MyersSquibbS.r.l. |
Croatia | (L01FF02) pembrolizumab | Keytruda | konc. za otop. za inf., boč. stakl. 1x100 mg/4 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Endometrial Neoplasms | MerckSharp&DohmeB.V. / Schering-PloughLaboNV |
Croatia | (L01FF03) durvalumab | Imfinzi | konc. za otop. za inf., boč. stakl. 1x120 mg/2,4 ml (50mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB / AstraZenecaPharmaceuticalsLP |
Croatia | (L01FF03) durvalumab | Imfinzi | konc. za otop. za inf., boč. stakl. 1x500 mg/10 ml (50mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB / AstraZenecaPharmaceuticalsLP |
Croatia | (L01FF05) atezolizumab | Tecentriq | konc. otop. za inf., boč. 1x1200 mg/20 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheRegistrationGmbH / RochePharmaAG |
Croatia | (L01FF05) atezolizumab | Tecentriq | konc. otop. za inf., boč. 1x840 mg/14 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheRegistrationGmbH / RochePharmaAG |
Croatia | (L01FF06) cemiplimab | Libtayo | konc. za otop. za inf., boč. 1x350 mg/7 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | RegeneronIrelandDesignedActivityCompany(DAC) / RegeneronIrelandDAC |
Croatia | (L01FG01) bevacizumab | Abevmy | konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | MylanIREHealthcareLtd / McDermottLaboratoriesLimitedt/aMylanDublinBiologics,MylanGermanyGmbH |
Croatia | (L01FG01) bevacizumab | Abevmy | konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | MylanIREHealthcareLtd / McDermottLaboratoriesLimitedt/aMylanDublinBiologics,MylanGermanyGmbH |
Croatia | (L01FG01) bevacizumab | Alymsys | konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | MabxienceResearchS.L. / GHGenhelixS.A. |
Croatia | (L01FG01) bevacizumab | Alymsys | konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | MabxienceResearchS.L. / GHGenhelixS.A. |